$14.96 B
Share price
Change (1 day)
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: $14.96 Billion

As of May 2022 Celltrion has a market cap of $14.96 Billion. This makes Celltrion the world's 1074th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Celltrion from 2007 to 2022

Year Market cap Change
2022$15.41 B-33.5%
2021$23.18 B-48.58%
2020$45.09 B126.46%
2019$19.91 B-19.83%
2018$24.83 B-3.51%
2017$25.74 B136.78%
2016$10.87 B34.5%
2015$8.08 B123.17%
2014$3.62 B1.53%
2013$3.56 B-17.91%
2012$4.34 B19%
2011$3.65 B5.92%
2010$3.44 B161.41%
2009$1.31 B63.51%
2008$0.80 B4217.29%
2007$0.01 B

End of Day market cap according to different sources

On May 15th, 2022 the market cap of Celltrion was reported to be:

$15.89 Billion
by Iex Cloud
$15.41 Billion
by CompaniesMarketCap
$20.204 Trillion
by Yahoo Finance